메뉴 건너뛰기




Volumn 271, Issue 24, 1996, Pages 14376-14382

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

Author keywords

[No Author keywords available]

Indexed keywords

2 (3,5 DI TERT BUTYL 4 HYDROXYPHENYL)ETHENYL 1,1 BISPHOSPHONIC ACID; 25 HYDROXYCHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MEVALONIC ACID; MEVINOLIN; SR 12813; UNCLASSIFIED DRUG;

EID: 15844402429     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.271.24.14376     Document Type: Article
Times cited : (44)

References (48)
  • 29
    • 0014949207 scopus 로고
    • Laemmli, U. K. (1970) Nature 227, 680-685
    • (1970) Nature , vol.227 , pp. 680-685
    • Laemmli, U.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.